Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome after Allogeneic Stem Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network Protocol

Idiopathic pneumonia syndrome (IPS) is a diffuse, noninfectious lung injury that occurs acutely after allogeneic hematopoietic cell transplantation (HCT). IPS-related mortality has been historically high (>50%) despite treatment with systemic corticosteroids and supportive care measures. We have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yanik, Gregory A., Horowitz, Mary M., Weisdorf, Daniel J., Logan, Brent R., Ho, Vincent T., Soiffer, Robert J., Carter, Shelly L., Wu, Juan, Wingard, John R., Difronzo, Nancy L., Ferrara, James L., Giralt, Sergio, Madtes, David K., Drexler, Rebecca, White, Eric S., Cooke, Kenneth R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128626/
https://ncbi.nlm.nih.gov/pubmed/24607553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.02.026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge